Teratake, Yoichi
Takashina, Tomoki
Iijima, Kenta
Sakuma, Tetsushi
Yamamoto, Takashi
Ishizaka, Yukihito
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP16ck0106235)
Article History
Received: 21 August 2019
Revised: 20 November 2019
Accepted: 11 December 2019
First Online: 21 January 2020
Ethics approval and consent to participate
: The protocol of experiments conducted by using human materials was designed in accordance with the Declaration of Helsinki and approved by the Internal Review Board of the National Centre for Global Health and Medicine (Ref. No. NCGM-A-000268-00). Peripheral blood was isolated from healthy donors who gave written informed consents. The protocols of animal experiments were approved by the committee of Institutional Animal Care and Use (Ref. No. 19055).
: All data presented within the article and its InternalRef removed are available upon request from the corresponding author.
: The authors declare no competing interests
: This work was supported in parts by Grants-in-Aid for Research from the Programme for Basic and Clinical Research on the Practical Research for Innovative Cancer Control, ‘Secure System of Genome Editing and Application to Cancer Immunotherapy’ (JP16ck0106235) from the Agency for Medical Research and Development (AMED), Japan, and the National Centre for Global Health and Medicine (NCGM) grant [22A-301].